登录 | 注册    关注公众号  
微信公众号
搜索
 > 【DPPIV】

DPPIV信息

英文名称:Dipeptidyl peptidase IV
中文名称:二肽基肽酶IV
靶点别称:Dipeptidyl peptidase IV membrane form,T-cell activation antigen CD26,Adenosine deaminase complexing protein 2,Dipeptidyl peptidase IV,Dipeptidyl peptidase IV soluble form,ADCP2,Dipeptidyl peptidase 4,ADCP-2,ADABP,DPP4,Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2),DPP IV,TP103,CD26,Dipeptidyl-Peptidase 4,Dipeptidylpeptidase 4,CD26 Antigen,DPPIV,Xaa-Pro-Dipeptidylaminopeptidase,Gly-Pro Naphthylamidase,Post-Proline Dipeptidyl Aminopeptidase IV
上市药物数量:34
临床药物数量:35
最高研发阶段:批准上市

DPPIV分子别名

DPP4,ADABP,ADCP2,CD26,DPPIV,TP103

DPPIV分子背景

Dipeptidyl peptidase-IV (DPPIV) is also known as adenosine deaminase complexing protein 2, DPPIV or CD26 is antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. It is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPPIV are proline (or alanine)-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1. DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others. DPPIV also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

DPPIV上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

DPPIV临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定